BRIEF
OWN INTERNAL MEDICINE EVENT is Roche’s largest Auto-Imune disease related event currently in its 12th Edition.
Internal medicine accounts for 40% of Roche’s business. The 12th Edition theme is The present and the future of auto-imune disease, mainly those that are targeted with Tocilizumab (RoActemra) such as Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Giant Cell Arthritis and possibly in the future, Systemic Sclerosis.
With biosimilar medicines breaking in the market the event aims to position RoActemra for the medical community as an innovative drug providing a therapeutic alternative with greater effectiveness than other drugs and showcase Roche’s commitment to the evolution of the treatment paradigm in these diseases within constant scientific innovation.
'Transforming lifes: helping patients to feel free again' is at the core of the brand’s ethos; intentively the identity of the event should stand on the premise of the effectiveness and quality of life that can be achieved with RoActemra medication.
Keywords: auto-immune, internal medicine, immunology, joints, movement, freedom
— Proposal for invitation pitch —

key concepts

Stage

Check-in desk, roll-up banner, schedule

attendance badges, conference guide, note pad + pen

'save the date' and invitation

Back to Top